- Corporate Officers - H
- Hillhouse Investment Management, Ltd.
Insider Trading History of Hillhouse Investment Management, Ltd.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hillhouse Investment Management, Ltd. since 2016.
This trader's CIK number is 1510589.
At the time of last reporting, Hillhouse Investment Management, Ltd. was the Officer of Beigene, Ltd.. (stock ticker symbol BGNE).
Also see all insider trading activities at Beigene, Ltd..
Note that in the past
HILLHOUSE INVESTMENT MANAGEMENT, LTD. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Beigene, Ltd. (BGNE) by Hillhouse Investment Management, Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | BGNE | 0 | $0 | 17,842,500 | $3,568,500,000 | 0 | $0 |
| 2023 | BGNE | 0 | $0 | 4,154,817 | $777,586,761 | 0 | $0 |
| 2016 | BGNE | 9,100,000 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Apellis Pharmaceuticals, Inc. (APLS) by Hillhouse Investment Management, Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | APLS | 1,428,571 | $19,999,994 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Enfusion, Inc. (ENFN) by Hillhouse Investment Management, Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ENFN | 0 | $0 | 647,862 | $10,297,766 | 0 | $0 |
Insider trading activities at 3 companies by Hillhouse Investment Management, Ltd.:
1. Beigene, Ltd. (BGNE)
2. Apellis Pharmaceuticals, Inc. (APLS)
3. Enfusion, Inc. (ENFN)
Table 1. Insider trading of Beigene, Ltd. (BGNE) by Hillhouse Investment Management, Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-02 | BGNE | Sale | 17,842,500 | 200.00 | 3,568,500,000 |
| 2023-06-14 | BGNE | Sale | 273,728 | 207.72 | 56,857,958 |
| 2023-06-13 | BGNE | Sale | 924,400 | 169.94 | 157,095,309 |
| 2023-06-12 | BGNE | Sale | 1,250,212 | 172.37 | 215,501,542 |
| 2023-06-09 | BGNE | Sale | 542,652 | 173.69 | 94,250,512 |
| 2023-06-08 | BGNE | Sale | 1,163,825 | 218.14 | 253,881,440 |
| 2016-02-08 | BGNE | Buy | 9,100,000 | .00 | 0 |
Table 2. Insider trading of Apellis Pharmaceuticals, Inc. (APLS) by Hillhouse Investment Management, Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-11-13 | APLS | Buy | 1,428,571 | 14.00 | 19,999,994 |
Table 3. Insider trading of Enfusion, Inc. (ENFN) by Hillhouse Investment Management, Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-10-25 | ENFN | Sale | 647,862 | 15.89 | 10,297,766 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hillhouse Investment Management, Ltd.
(Officer of Beigene, Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.